AI Article Synopsis

  • Mucin 1 (MUC1) and KL-6 are being studied as potential serum biomarkers for interstitial lung diseases (ILDs), particularly in Caucasian patients with antisynthetase syndrome (ASSD).
  • In a study involving 168 ASSD patients, 174 idiopathic pulmonary fibrosis (IPF) patients, and 523 healthy controls, the MUC1 rs4072037 C allele was found to be significantly more common in ASSD patients compared to controls.
  • Although serum KL-6 levels were higher in ASSD patients versus healthy individuals, they did not differ between ASSD-ILD+ and IPF patients, suggesting that MUC1 rs4072037 C allele might be a useful genetic

Article Abstract

Mucin 1/Krebs von den Lungen-6 (KL-6) is proposed as a serum biomarker of several interstitial lung diseases (ILDs), including connective tissue disorders associated with ILD. However, it has not been studied in a large cohort of Caucasian antisynthetase syndrome (ASSD) patients. Consequently, we assessed the role of MUC1 rs4072037 and serum KL-6 levels as a potential biomarker of ASSD susceptibility and for the differential diagnosis between patients with ILD associated with ASSD (ASSD-ILD +) and idiopathic pulmonary fibrosis (IPF). 168 ASSD patients (149 ASSD-ILD +), 174 IPF patients and 523 healthy controls were genotyped for MUC1 rs4072037 T > C. Serum KL-6 levels were determined in a subgroup of individuals. A significant increase of MUC1 rs4072037 CC genotype and C allele frequencies was observed in ASSD patients compared to healthy controls. Likewise, MUC1 rs4072037 TC and CC genotypes and C allele frequencies were significantly different between ASSD-ILD+ and IPF patients. Additionally, serum KL-6 levels were significantly higher in ASSD patients compared to healthy controls. Nevertheless, no differences in serum KL-6 levels were found between ASSD-ILD+ and IPF patients. Our results suggest that the presence of MUC1 rs4072037 C allele increases the risk of ASSD and it could be a useful genetic biomarker for the differential diagnosis between ASSD-ILD+ and IPF patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604941PMC
http://dx.doi.org/10.1038/s41598-021-01992-yDOI Listing

Publication Analysis

Top Keywords

muc1 rs4072037
24
serum kl-6
20
kl-6 levels
20
assd patients
16
ipf patients
16
healthy controls
12
assd-ild+ ipf
12
patients
10
role muc1
8
antisynthetase syndrome
8

Similar Publications

Article Synopsis
  • The study investigates the relationship between the rs4072037G>A gene polymorphism and gastric cancer susceptibility, particularly in the context of infection in patients from northern Iran.
  • A case-control design involved 99 gastric cancer patients and 98 controls, assessing infection through histological examination and genetic analysis via PCR-RFLP.
  • Results indicate no direct link between the polymorphism and gastric cancer risk, but suggest that it may increase susceptibility to gastric cancer when combined with infection, particularly in specific genetic models.
View Article and Find Full Text PDF

Background/aim: Although the expression of mucin 1(MUC1) and prostate stem cell antigen (PSCA) genes is correlated with gastric cancer development and progression, the utility of these two genes as biomarkers of gastric cancer prognosis still needs to be confirmed in clinical practice. This study aimed to develop a model predictive of gastric cancer that integrates several significant single nucleotide polymorphisms (SNPs) of MUC1 and PSCA genes, and some health-risk behavior factors in a Vietnamese population.

Patients And Methods: A total of 302 patients with primary gastric carcinoma and 304 healthy persons were included in a case-control study.

View Article and Find Full Text PDF

The interplay between genetic and environmental factors influences the course of chronic kidney disease (CKD). In this context, genetic alterations in the kidney disease gene (Mucin1) predispose to the development of CKD. These variations comprise the polymorphism rs4072037, which alters splicing of MUC1 mRNA, the length of a region with variable number of tandem repeats (VNTR), and rare autosomal-dominant inherited dominant-negative mutations in or 5' to the VNTR that causes autosomal dominant tubulointerstitial kidney disease (ADTKD-).

View Article and Find Full Text PDF
Article Synopsis
  • Serum KL-6 is a biomarker that can help predict critical outcomes in COVID-19 patients, showing significantly higher levels in those with severe cases compared to milder ones.
  • In a study of 2,226 Japanese COVID-19 patients, a serum KL-6 level of ≥304 U/mL was a strong predictor of critical outcomes.
  • The mucin 1 variant was correlated with increased KL-6 levels but did not show a significant relationship with the severity of COVID-19 outcomes.
View Article and Find Full Text PDF

Background: Gout is a highly hereditary disease, but not all those carrying well-known risk variants have developing gout attack even in hyperuricemia status. We performed a genome-wide association study (GWAS) and polygenic risk score (PRS) analysis to illustrate the new genetic architectures of gout and asymptomatic hyperuricemia (AH).

Methods: GWAS was performed to identify variants associated with gout/AH compared with normouricemia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!